Robeco Institutional Asset Management B.V. Novavax Inc Transaction History

Robeco Institutional Asset Management B.V.

$51.9 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$36.28 - $75.29 $256,427 - $532,149	-7,068 Closed	0 $0
Q4 2021 Dec 01, 2022	SELL	$134.56 - $217.97 $154,878 - $250,883	-1,151 Reduced 14.0%	7,068 $1.01 Million
Q4 2021 Jan 31, 2022	SELL	$134.56 - $217.97 $154,878 - $250,883	-1,151 Reduced 14.0%	7,068 $1.01 Million
Q3 2021 Dec 01, 2022	BUY	$177.8 - $270.58 $316,661 - $481,902	1,781 Added 27.66%	8,219 $1.71 Million
Q3 2021 Oct 20, 2021	BUY	$177.8 - $270.58 $316,661 - $481,902	1,781 Added 27.66%	8,219 $1.71 Million
Q2 2021 Dec 01, 2022	BUY	$121.0 - $257.67 $778,998 - $1.66 Million	6,438 New	6,438 $1.37 Million
Q2 2021 Jul 28, 2021	BUY	$121.0 - $257.67 $778,998 - $1.66 Million	6,438 New	6,438 $1.37 Million

Others Institutions Holding NVAX

# of Institutions

287

Shares Held

94.7M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $689M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account